Xtl Biopharmaceuticals (XTLB) Income towards Parent Company (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) reported Income towards Parent Company of -$6.97 million for the year ended Dec 31, 2025, compared with -$1.03 million a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Income towards Parent Company (2009 - 2024) Analysis & Trends
Dating back to the year ended Dec 31, 2009, Xtl Biopharmaceuticals' Income towards Parent Company record includes 17 years.
- The figure for the year ended Dec 31, 2025 ranks as the lowest annual Income towards Parent Company in data going back to the year ended Dec 31, 2009.
- According to Business Quant data, Income towards Parent Company came in at -$1.03 million in the year ended Dec 31, 2024, -$1.78 million in the year ended Dec 31, 2023, -$1.35 million in the year ended Dec 31, 2022 and $435,000 in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Xtl Biopharmaceuticals | 2.03 Bn | 2.03 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -255,000.00 |
| Sep 30, 2024 | -553,000.00 |
| Jun 30, 2024 | -421,000.00 |
| Mar 31, 2024 | -175,000.00 |
| Dec 31, 2023 | -284,000.00 |
| Sep 30, 2023 | -215,000.00 |
| Jun 30, 2023 | -163,000.00 |
| Mar 31, 2023 | -251,000.00 |
| Dec 31, 2022 | -748,000.00 |
| Sep 30, 2022 | -821,000.00 |
| Jun 30, 2022 | -285,000.00 |
| Mar 31, 2022 | -249,000.00 |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | -795,000.00 |
| Jun 30, 2021 | -1.15 Mn |
| Mar 31, 2021 | 286,000.00 |
| Dec 31, 2020 | -1.08 Mn |
| Sep 30, 2020 | -946,000.00 |
| Jun 30, 2020 | -1.11 Mn |
| Mar 31, 2020 | 173,000.00 |
API Access
Xtl Biopharmaceuticals Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();